메뉴 건너뛰기




Volumn 87, Issue 4, 2002, Pages 555-556

Maximized hemostasis

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; CARBOXYPEPTIDASE B; FIBRIN; HEPARIN; MELAGATRAN; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

EID: 0036219682     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613048     Document Type: Note
Times cited : (1)

References (20)
  • 2
    • 0024412863 scopus 로고
    • An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxy-peptidase N or its subunits
    • (1989) Biochem Biophys Res Commun , vol.162 , pp. 933-939
    • Campbell, W.1    Okada, H.2
  • 6
    • 0029895009 scopus 로고    scopus 로고
    • TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascade through the thrombin-thrombomodulin complex
    • (1996) J Biol Chem , vol.271 , pp. 16603-16608
    • Bajzar, L.1    Morser, J.2    Nesheim, M.E.3
  • 9
    • 0031935464 scopus 로고    scopus 로고
    • Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma carboxypeptidase B
    • (1998) Thromb Haemost , vol.79 , pp. 371-377
    • Hosaka, Y.1    Takahashi, Y.2    Ishii, H.3
  • 16
    • 0032463227 scopus 로고    scopus 로고
    • Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone
    • (1998) Haemostasis , vol.28 , pp. 99-105
    • Reganon, E.1    Ferrando, F.2    Vila, V.3
  • 17
    • 0034657826 scopus 로고    scopus 로고
    • An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model
    • (2000) Thromb Res , vol.98 , pp. 333-342
    • Nagashima, M.1    Werner, M.2    Wang, M.3
  • 19
    • 0036214635 scopus 로고    scopus 로고
    • Local proCPU (TAFI) activation during thrombolytic treatment in a dog model of coronary artery thrombosis can be inhibited with a direct, small molecule thrombin inhibitor (melagatran)
    • (2002) Thromb Haemost , vol.87 , pp. 557-562
    • Mattsson, C.1    Bjorkman, J.A.2    Abrahamsson, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.